https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Dynamic Landscape of Extracellular Vesicle-Associated Proteins Is Related to Treatment Response of Patients with Metastatic Breast Cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40283 Wed 13 Mar 2024 08:47:04 AEDT ]]> Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:995 Sat 24 Mar 2018 08:29:49 AEDT ]]> Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10716 Sat 24 Mar 2018 08:08:26 AEDT ]]> A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45453 Fri 28 Oct 2022 14:15:24 AEDT ]]>